Level Brands Inc., a marketing and licensing company that provides bold, unconventional, and socially responsible branding for leading businesses, and Vancouver-based Isodiol International Inc. (CSE: ISOL, OTCQB: ISOLF), a global bioactive phytoceutical innovator, specializing in the development of pharmaceutical and wellness products, announced the launch of their newest jointly developed cannabidiol (CBD) products. The products are CBD pain-relieving cream, marketed under LEVB subsidiary Ireland Men One (I’M1); CBD oral sprays marketed under BeTrū | kathy ireland® Health & Wellness; and CBD edibles, marketed under Chef Andre Carthen Edibles. The new products will be available in early Summer 2018 at in-store and online retailers nationwide. According to The Hemp Business Journal (as reported by forbes.com), the CBD market will grow to $2.1 billion by 2020.

In January 2018, Level Brands and Isodiol signed a license agreement, to work together to develop consumer products for kathy ireland® Health & Wellness, a licensor to Level Brands; products under the Chef Andre Carthen and Nicholas Walker brands, also licensors to Level Brands; as well as products for Level Brands subsidiary I’M1, the company’s lifestyle brand for millennial men. The license agreement is valued at $32 million.

Stephen Roseberry and Jon Carrasco serve as President & CMO, and Global Creative Director, respectively, for kathy ireland® Worldwide and all of its Level Brands licensing entities, including I’M1,

kathy ireland® Health & Wellness, and EE1, the brand management subsidiary, co-founded by Nic Mendoza. All CBD products are THC-free and non-psychoactive while focusing on the natural, positive effects CBD has on our bodies. All products use hemp-derived, 99%+ pure, bioactive, and pharmaceutical-grade CBD. The products promote a holistic and natural lifestyle and are made in the USA.

Level Brands Inc.

Isodiol International Inc.